Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.209
-0.036 (-14.82%)
At close: Apr 28, 2026, 4:00 PM EDT
0.204
-0.004 (-2.11%)
After-hours: Apr 28, 2026, 4:22 PM EDT
Aspire Biopharma Holdings Revenue
In the year 2025, Aspire Biopharma Holdings had annual revenue of $6.20K. Aspire Biopharma Holdings had revenue of $4.26K in the quarter ending December 31, 2025.
Revenue (ttm)
$6.20K
Revenue Growth
n/a
P/S Ratio
198.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.20K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionASBP News
- 1 day ago - Aspire Biopharma Announces $5.0 Million Share Repurchase Program - Accesswire
- 8 days ago - Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition - Accesswire
- 11 days ago - Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo - Accesswire
- 12 days ago - Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue - Accesswire
- 13 days ago - Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion - Accesswire
- 5 weeks ago - Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Accesswire
- 6 weeks ago - Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - Accesswire
- 6 weeks ago - Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - Accesswire